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The meningococcus is an important cause of morbidity and mortality and a rapid laboratory diagnosis
is required through accurate, non-culture-based methods. Body fluids that are easily obtainable are preferred
for this route of diagnosis and urine is the specimen of choice as it can be obtained non-invasively. Urine
samples were tested from patients with suspected meningococcal disease and tested by latex agglutination
and PCR. It was shown that urinary PCR is not useful for the laboratory confirmation of MD but latex
agglutination testing may be useful in certain settings prior to confirmatory testing by a reference laboratory.
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The meningococcus is one of the main causes of meningitis,
particularly in countries where conjugate vaccines against
Haemophilus influenzae type b disease have been introduced,
and is an important cause of morbidity and mortality [1,2]. The
search for new therapeutic and diagnostic methods therefore
continues, with the aims of reducing the morbidity and
mortality associated with meningococcal disease (MD), and
performing effective surveillance of the disease. Although
polysaccharide vaccines have been available for the prevention
of a number of serogroups of MD, these vaccines have generally
had a short duration of protection and could not be used in
young children. New conjugate vaccines are now available for
the prevention of serogroup C MD [3,4], but there are no
conjugate vaccines yet available for the prevention of other
invasive meningococcal serogroups.
As technology improves, new methods are becoming avail-
able for the laboratory confirmation of MD. These include
PCR and DNA sequencing methods [5,6]. Automation is also
becoming increasingly used as it becomes affordable [7]. How-
ever, most of these methods are limited to specialised labora-
tories and therefore result in reporting delays. To enable a rapid
diagnosis of MD to be made local diagnostic microbiology labo-
ratories require access to quick but accurate methods [8]. Owing
to the common use of antibiotics prior to hospital admission
[9], non-culture confirmation of disease is important, although
every effort should be made to gain a culture confirmation.
Methods are therefore required that can provide a rapid,
accurate and non-culture diagnostic route to confirm a clinical
suspicion of MD. Body fluids that are easily obtainable are
preferred for this route of diagnosis, and urine is the specimen of
choice, because it can usually be obtained non-invasively. As all
PCR requests for the laboratory confirmation of MD in
Scotland are forwarded to the ScottishMeningococcus andPneu-
mococcus Reference Laboratory (SMPRL), and there is a delay
due to postal and testing time, testing for urinary antigen would
be a rapid and cost-effective screening method for MD in a local
diagnostic laboratory. Urines that are positive by latex agglu-
tination could then be forwarded to the reference laboratory for
further testing. Two preliminary studies have been performed
for the rapid detection of meningococcal antigen in urine
[10,11], but the number of samples used was small. Here we
describe the usefulness of latex agglutination and PCR testing
on unconcentrated and concentrated urine for the laboratory
confirmation of MD.
A request was made to all diagnostic microbiology labora-
tories throughout Scotland to send urine samples from patients
suspected of having MD. Urines were taken at the onset of
illness and sent to the SMPRL for testing. All testing was
performed on unconcentrated and concentrated urine. Uncon-
centrated urine was boiled for 5 min Concentration of urine was
initially performed with 5 mL, using the commercially avail-
able Millipore Minicon B15 concentration system (Amicon,
Millipore, Watford, UK), according to the manufacturer’s in-
structions. However, this was found to result in inhibition of the
PCR reaction, and was therefore replaced with the Vivapore 5
(Sartorius, Epsom, Surrey, UK), a similar method that could be
used for comparison. After concentration, the urine was again
boiled for 5 min Unconcentrated and concentrated urines were
tested for the presence of meningococcal antigen using the
Wellcogen latex agglutination test (Abbot Diagnostics, Maiden-
head, UK). Urines that were positive for serogroups A, C, Yand
W135 by latex agglutination were tested further by coagglu-
tination to determine the individual serogroup [12]. Uncon-
centrated and concentrated urines were also tested for the
presence of meningococcal antigen, using PCR to detect
the insertion element IS1106, as previously described [13,14].
Between August 1999 and July 2000, a total of 133 urines
were received from 128 patients and tested for the presence of
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meningococcal antigen as described. The first 59 urines were
tested by the Millipore Minicon B15 method, and eight urines
were positive for meningococcal antigen by latex agglutination,
as previously reported [11]. Five of these were serogroup B, and
three were serogroup C. The remaining 51 urines were negative
by latex agglutination. Only one urine of these 51 was positive
by PCR after concentration (urine 9, Table 1), and it had been
negative by latex agglutination. Further testing on this patient
by a meningococcal outer membrane protein (OMP) serum
antibody ELISA method suggested that the patient did not have
MD. PCR inhibition factors were present in eight (14%)
unconcentrated urines and 19 (32%) concentrated urines.
Owing to the high number of urines possessing these inhibition
factors after concentration using the Millipore system, the
concentration technique was replaced with the Vivapore 5
system. A further 74 urines were tested by latex agglutination
and PCR. No urines were positive by either latex agglutination
or PCR when unconcentrated or concentrated samples were
used. Inhibition factors were again common, being found in 37
(50%) of samples. Summarised results are shown in Table 2.
Antigen detection tests are routinely used by the SMPRL and
can provide sensitive and specific methods for the confirmation
of MD [6]. Blood or cerebrospinal fluid are the samples
routinely used for antigen detection, because urine has never
been evaluated for its usefulness. However, it is well known that
latex agglutination tests, although highly sensitive, often pro-
duce false positives, particularly in the presence of proteins
normally found in urine [15]. Latex agglutination could be used
as a screening assay, followed by the PCR test as a more sensitive
and specific assay, with the possibility of confirming the
serogroup of infection using the siaD PCR method [16]. In
this study, 133 urine samples from 128 patients with suspected
MD were analyzed. Concentration of the urine did not affect
the latex agglutination result. Three of the latex agglutination-
positive urines were confirmed by other methods, while the
other five were not confirmed, either because other tests were
negative or because no other samples were received. Latex
agglutination of urine for the confirmation of MD may there-
fore be useful as an urgent measure for confirming and obtain-
ing the serogroup of the infecting meningococcus in local
diagnostic laboratories where PCR testing is not available.
Further testing and confirmation may then be achieved at a
reference laboratory, where other tests using samples other than
urine, such as whole blood or cerebrospinal fluid, may be used.
The urinary PCR test was not useful for the laboratory
confirmation of MD. All but one of the urines tested were
negative for the insertion element IS1106, using both uncon-
centrated and concentrated urine. The concentrated urine that
was positive by PCR was not confirmed by other methods and
may have been a false-positive result. The concentration of
urine using either commercial system increased the number of
urines that exhibited factors resulting in inhibition of the PCR
reaction. These factors may cause such inhibition by reducing
the amount of available magnesium ions in the PCR reaction
mix [17]. Although this can be counteracted by increasing the
magnesium ion concentration, the variability in the amount of
inhibitor may result in a less rigid PCR assay for clinical
diagnostic use. Normally, the IS1106 PCR assay is very useful
for the laboratory confirmation of MD using other body fluids,
such as whole blood or cerebrospinal fluid [6]. Although false-
positive results using this gene target have been reported [18],
this was generally not a problem in this study. True positives can
often be confirmed by other slightly less sensitive PCR assays
that detect the ctrA and siaD genes, respectively [5,16], although
this was not the case for this positive.
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Pyogenic hepatic abscess: clues for diagnosis in the emergency room
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The objective of this paper is to describe the clinical and diagnostic characteristics of patients with
pyogenic hepatic abscesses evaluated in the emergency room, and to know whether it is feasible to make an
early diagnosis based on any of these characteristics. The setting was an urban, tertiary-care teaching
hospital. This was a retrospective study of 63 adult patients admitted to our institution because of
pyogenic liver abscesses from January 1991 to December 1998.
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INTRODUCTION
Pyogenic hepatic abscess (PHA) represents an infrequent and
sometimes life-threatening entity [1]. Its recognition has clearly
improved in the last decade through the development of more
sensitive and specific imaging techniques, such as ultrasono-
graphy (US) and computed tomography (CT), with their
relevant therapeutic implications [2,3]. Standard treatment
protocols usually recommend a combination of drainage and
antimicrobial therapy, although no specific antibiotic schemes
have been defined due to the lack of large, prospective studies [4].
Diagnosing PHA in an initial stage remains a difficult task
today, frequently due to the paucity of the presenting symptoms
or the radiological features. However, several studies have
confirmed that an early diagnosis is associated with improved
survival [5–7].
This study will describe the clinical and diagnostic charac-
teristics of patients with PHA evaluated at a first-step hospital
level, the emergency room (ER).
PATIENTS AND METHODS
The medical records of all adult patients admitted between
January 1991 and December 1998 at the Marque´s de
Valdecilla University Hospital, and discharged with a diagnosis
of PHA, were reviewed. This is an 1100-bed tertiary-care center
that serves as the reference hospital for a population of 500 000,
and as the first-level hospital for an area including about 350 000
inhabitants in Northern Spain. Therefore, this population
can be regarded as an unselected sample of this entity in our area.
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